
Multiple lung carcinomas are 5 to 11,5% of lung carcinomas. The distinction between primary lung carcinomas from carcinomas with intrapulmonary metastasis is essential for optimal patient management. The histopathological analysis is very useful but it has to be completed by genotypic assessment using molecular biology (NGS). Molecular biology can also identify genetic alterations with therapeutic implications. We present the case of a patient with a history of surgery for multiple lung carcinomas diagnosed from 2013 to 2017.
Lung Neoplasms, Carcinoma, Acinar Cell, Disease Management, Adenocarcinoma of Lung, Neoplasms, Second Primary, Middle Aged, Combined Modality Therapy, Diagnosis, Differential, Neoplasms, Multiple Primary, Adenocarcinoma, Papillary, Chemotherapy, Adjuvant, Biomarkers, Tumor, Humans, Female, Pneumonectomy
Lung Neoplasms, Carcinoma, Acinar Cell, Disease Management, Adenocarcinoma of Lung, Neoplasms, Second Primary, Middle Aged, Combined Modality Therapy, Diagnosis, Differential, Neoplasms, Multiple Primary, Adenocarcinoma, Papillary, Chemotherapy, Adjuvant, Biomarkers, Tumor, Humans, Female, Pneumonectomy
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
